Brexit – medicines, medical devices and substances of human origin inquiry – Regulatory arrangements needed to guarantee safe and effective supply of medicines, medical devices and products post-Brexit

As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to UK House of Commons in 2017 about Brexit – medicines, medical devices and substances of human origin inquiry – Regulatory arrangements needed to guarantee safe and effective supply of medicines, medical devices and products post-Brexit can be found below.